Literature DB >> 2776879

Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3'-terminus and their interaction with DNA within mammalian cells.

A S Boutorin1, L V Gus'kova, E M Ivanova, N D Kobetz, V F Zarytova, A S Ryte, L V Yurchenko, V V Vlassov.   

Abstract

5'-[32P]-labelled alkylating decathymidylate [4-(N-2-chloroethyl)N-methylaminobenzyl]-5'-phosphamide derivatives containing cholesterol or phenazinium residues at their 3'-termini were synthesized and used for alkylation of DNA within mammalian cells. The uptake of the cholesterol derivative by the cells and the extent of DNA alkylation are about two orders of magnitude higher than those of a similar alkylating derivative lacking the groups at the 3'-termini. The presence of the phenazinium residue at the 3'-terminus of the oligonucleotide reagent does not improve the reagent uptake by the cells but drastically increases the DNA modification efficiency.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2776879     DOI: 10.1016/0014-5793(89)81023-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

1.  Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups.

Authors:  C MacKellar; D Graham; D W Will; S Burgess; T Brown
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

2.  Intracellular distribution of microinjected antisense oligonucleotides.

Authors:  J P Leonetti; N Mechti; G Degols; C Gagnor; B Lebleu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

3.  Effects of linker sequences on vesicle fusion mediated by lipid-anchored DNA oligonucleotides.

Authors:  Yee-Hung M Chan; Bettina van Lengerich; Steven G Boxer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

Review 4.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

5.  Bioavailability of antisense oligonucleotides in neuroblastoma cells: comparison of efficacy among different types of molecules.

Authors:  M V Corrias; F Guarnaccia; M Ponzoni
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

Review 6.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

Review 7.  Nucleoside, nucleotide and oligonucleotide based amphiphiles: a successful marriage of nucleic acids with lipids.

Authors:  Arnaud Gissot; Michel Camplo; Mark W Grinstaff; Philippe Barthélémy
Journal:  Org Biomol Chem       Date:  2008-03-05       Impact factor: 3.876

Review 8.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

9.  Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates.

Authors:  E Bonfils; C Depierreux; P Midoux; N T Thuong; M Monsigny; A C Roche
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

10.  Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.

Authors:  A M Krieg; J Tonkinson; S Matson; Q Zhao; M Saxon; L M Zhang; U Bhanja; L Yakubov; C A Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.